News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,869 Results
Type
Article (42116)
Company Profile (278)
Press Release (688465)
Multimedia
Podcasts (82)
Webinars (18)
Section
Business (207213)
Career Advice (2037)
Deals (35938)
Drug Delivery (110)
Drug Development (81628)
Employer Resources (173)
FDA (16605)
Job Trends (15069)
News (349977)
Policy (33044)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2611)
Accelerated approval (32)
Adcomms (24)
Allergies (143)
Alliances (50490)
ALS (169)
Alzheimer's disease (1688)
Antibody-drug conjugate (ADC) (310)
Approvals (16875)
Artificial intelligence (532)
Autoimmune disease (155)
Automation (39)
Bankruptcy (365)
Best Places to Work (11703)
BIOSECURE Act (20)
Biosimilars (189)
Biotechnology (176)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (645)
Cancer (4842)
Cardiovascular disease (398)
Career advice (1722)
Career pathing (37)
CAR-T (283)
CDC (44)
Celiac Disease (2)
Cell therapy (744)
Cervical cancer (37)
Clinical research (69726)
Collaboration (1713)
Company closure (4)
Compensation (1159)
Complete response letters (54)
COVID-19 (2736)
CRISPR (90)
C-suite (849)
Cystic fibrosis (144)
Data (6237)
Decentralized trials (2)
Denatured (25)
Depression (133)
Diabetes (502)
Diagnostics (7097)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (254)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (232)
Earnings (90983)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (118582)
Executive appointments (982)
FDA (19738)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1482)
Gene editing (196)
Generative AI (48)
Gene therapy (597)
GLP-1 (967)
Government (4703)
Grass and pollen (6)
Guidances (384)
Healthcare (19072)
HIV (59)
Huntington's disease (44)
IgA nephropathy (83)
Immunology and inflammation (249)
Immuno-oncology (58)
Indications (110)
Infectious disease (3006)
Inflammatory bowel disease (188)
Inflation Reduction Act (14)
Influenza (117)
Intellectual property (249)
Interviews (318)
IPO (16799)
IRA (51)
Job creations (3703)
Job search strategy (1441)
JPM (57)
Kidney cancer (16)
Labor market (85)
Layoffs (549)
Leadership (31)
Legal (8001)
Liver cancer (93)
Longevity (14)
Lung cancer (652)
Lymphoma (377)
Machine learning (42)
Management (59)
Manufacturing (795)
MASH (164)
Medical device (13918)
Medtech (13972)
Mergers & acquisitions (20215)
Metabolic disorders (1270)
Multiple sclerosis (161)
NASH (16)
Neurodegenerative disease (315)
Neuropsychiatric disorders (88)
Neuroscience (2920)
Neurotech (1)
NextGen: Class of 2026 (6564)
Non-profit (4571)
Now hiring (67)
Obesity (595)
Opinion (260)
Ovarian cancer (167)
Pain (197)
Pancreatic cancer (228)
Parkinson's disease (281)
Partnered (33)
Patents (495)
Patient recruitment (491)
Peanut (57)
People (59558)
Pharmaceutical (63)
Pharmacy benefit managers (29)
Phase 1 (21734)
Phase 2 (30693)
Phase 3 (22855)
Pipeline (5290)
Policy (282)
Postmarket research (2568)
Preclinical (9230)
Press Release (66)
Prostate cancer (244)
Psychedelics (49)
Radiopharmaceuticals (287)
Rare diseases (832)
Real estate (6048)
Recruiting (70)
Regulatory (24734)
Reports (52)
Research institute (2429)
Resumes & cover letters (354)
Rett syndrome (27)
RNA editing (16)
RSV (77)
Schizophrenia (150)
Series A (243)
Series B (191)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3695)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (55)
Vaccines (1003)
Venture capital (90)
Weight loss (380)
Women's health (91)
Worklife (18)
Date
Today (105)
Last 7 days (614)
Last 30 days (2134)
Last 365 days (30175)
2026 (3442)
2025 (30437)
2024 (35514)
2023 (40431)
2022 (51552)
2021 (56105)
2020 (54582)
2019 (46972)
2018 (35404)
2017 (32523)
2016 (31989)
2015 (38123)
2014 (31796)
2013 (26920)
2012 (29106)
2011 (29799)
2010 (27788)
Location
Africa (753)
Alabama (83)
Alaska (7)
Arizona (311)
Arkansas (13)
Asia (40006)
Australia (6558)
California (11351)
Canada (3295)
China (1104)
Colorado (479)
Connecticut (478)
Delaware (336)
Europe (86885)
Florida (1692)
Georgia (362)
Hawaii (3)
Idaho (61)
Illinois (867)
India (65)
Indiana (523)
Iowa (23)
Japan (433)
Kansas (127)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1385)
Massachusetts (8121)
Michigan (324)
Minnesota (637)
Mississippi (5)
Missouri (131)
Montana (32)
Nebraska (28)
Nevada (123)
New Hampshire (82)
New Jersey (3009)
New Mexico (30)
New York (2988)
North Carolina (1501)
North Dakota (9)
Northern California (5526)
Ohio (335)
Oklahoma (21)
Oregon (41)
Pennsylvania (2277)
Puerto Rico (24)
Rhode Island (47)
South America (1126)
South Carolina (66)
South Dakota (1)
Southern California (4434)
Tennessee (176)
Texas (1757)
United States (40275)
Utah (340)
Vermont (1)
Virginia (261)
Washington D.C. (81)
Washington State (941)
West Virginia (4)
Wisconsin (121)
Wyoming (2)
730,869 Results for "bluejay diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production
December 29, 2025
·
4 min read
Press Releases
Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships
November 10, 2025
·
6 min read
Press Releases
Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform
October 9, 2025
·
4 min read
Press Releases
Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease
January 27, 2026
·
7 min read
Press Releases
Bluejay Diagnostics Provides Second Quarter Business and Corporate Update
August 8, 2025
·
6 min read
Press Releases
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
October 10, 2025
·
4 min read
Press Releases
Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
October 13, 2025
·
4 min read
Press Releases
Mirum Pharmaceuticals Enters into Definitive Agreement to Acquire Bluejay Therapeutics, Expanding Global Leadership in Rare Disease
December 9, 2025
·
11 min read
Deals
Bluejay Diagnostics Announces Reverse Stock Split
Bluejay Diagnostics, Inc. today announced that the Company’s Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1-for-8 (the “Reverse Stock Split”).
June 17, 2024
·
4 min read
Genetown
Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering
Bluejay Diagnostics, Inc. announced the closing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $8.75 million, before deducting underwriting discounts and other estimated expenses payable by the Company.
June 28, 2024
·
5 min read
1 of 73,087
Next
